Medication History Longitudinal Record

The record must establish a precise, sortable timeline of medication events—including start dates, discontinuation dates, and modification timestamps. This requires temporal reasoning to resolve conflicting dates from disparate sources (e.g., pharmacy claims vs. clinical notes) and to identify gaps in therapy. A valid record sequences events logically, ensuring a discontinuation order chronologically follows the initial prescription.

A robust record is a composite view built by ingesting and normalizing data from heterogeneous sources. This includes:

• Pharmacy Dispensing Records (PDMP/Surescripts)
• Electronic Health Record (EHR) Orders
• Patient-Reported Intake (BPMH)
• Insurance Claims Data The system must algorithmically resolve conflicts between these sources, flagging unintentional discrepancies for human review.

Every medication entry must be mapped to a standardized concept identifier to enable computational comparison. This involves:

• RxNorm mapping for active ingredient normalization
• Dose normalization to convert disparate strengths (e.g., '500mg' vs. '0.5g') into a comparable format
• Active ingredient matching to link brand names (e.g., 'Tylenol') to generics ('Acetaminophen'), preventing duplicate therapy errors.

Every data point must carry an audit trail of its origin. Data provenance tracks the source system, original timestamp, and any transformations applied. This traceability is critical for clinical safety, allowing a pharmacist to instantly verify if a dosage came from a verified pharmacy fill or an ambiguous patient recollection. Source attribution links each entry back to the raw text or database field.

The record must capture not just the 'what' but the 'why' and 'how'. This includes structured fields for:

• Indication: The diagnosis linked to the prescription
• Sig: The full patient-facing directions (dose, route, frequency)
• PRN Status: Whether the medication is taken as needed
• Negation Status: Using algorithms like NegEx to distinguish active medications from historical or discontinued ones mentioned in narrative notes.

The record serves as the input for automated safety checks. It must be structured to support real-time rules engines that evaluate:

• Prospective Drug-Drug Interactions (PDDIs)
• Allergen Cross-Reactivity against documented allergies
• Renal Dose Adjustments based on the latest eGFR lab value
• Beers Criteria violations for geriatric patients These filters transform the static record into a dynamic safety tool.

The documented audit trail that tracks the origin, source system, and transformation history of a specific medication data point. In a longitudinal record, provenance ensures that every entry—whether from a pharmacy dispense record, a patient self-report, or an inpatient administration—is traceable to its raw source. This traceability is critical for clinical safety validation, allowing a pharmacist to weight the reliability of conflicting entries and understand exactly how a structured value was derived from unstructured text.

The capability of an AI system to chronologically sequence clinical events to validate the logical consistency of a medication timeline. A longitudinal record requires temporal reasoning to resolve contradictions such as:

• A medication start date occurring after a documented discontinuation date
• Overlapping prescriptions for the same therapeutic class from different providers
• Identifying gaps in therapy during care transitions Without robust temporal ordering, the record becomes a flat list rather than a coherent narrative of medication exposure over time.

The mechanism of explicitly linking each extracted medication entry back to the specific sentence, document, or database field from which it was derived. In a consolidated longitudinal record, source attribution enables rapid human verification by surfacing the original context—such as a discharge summary paragraph or a pharmacy claims record—directly alongside the structured entry. This transparency is essential for resolving discrepancies where two sources conflict about a patient's actual medication regimen.

The computational process of converting disparate representations of medication strength and frequency into a standardized, comparable format. A longitudinal record must normalize entries like:

• "Metoprolol 25mg BID" and "Metoprolol Succinate 50mg daily"
• "Warfarin 5mg M-W-F" and "Warfarin 2.5mg alternating with 5mg" This standardization enables accurate calculation of cumulative exposure, detection of unintentional dose changes across encounters, and proper flagging of therapeutic duplication.

A probabilistic gate that routes AI-extracted medication data for human review only when the model's prediction score falls below a predefined certainty level. In building a longitudinal record, confidence thresholding optimizes the balance between full automation and patient safety:

• High-confidence entries are auto-populated into the timeline
• Low-confidence entries are queued for pharmacist verification
• Uncertain temporal relationships are flagged for manual sequencing This triage mechanism prevents the record from being contaminated by plausible-sounding but incorrect extractions.

The algorithmic technique of linking brand-name and generic drug products by resolving their chemical constituents to a common base compound. A longitudinal record spanning multiple encounters will inevitably contain entries like "Lipitor 20mg" from one visit and "Atorvastatin 20mg" from another. Active ingredient matching, powered by RxNorm concept unique identifiers, prevents these from appearing as separate medications and triggering false duplicate therapy alerts.